NYX Cosmetics expands Target retail partnership
LOS ANGELES — Beauty brand NYX Cosmetics has expanded its retail distribution through a partnership with Target.
After positive reaction to its entry in Target’s Canadian market, as well as a successful test launch domestically, NYX is now available in more than 1,000 Target stores across North America.
NYX’s partnership with Target first began in Canada where they launched in 2013. NYX is now available in 1,093 Target stores across the United States, with the remaining door openings planned for early 2014. In addition, NYX and Target will collaborate on marketing initiatives featuring best-selling NYX items in limited-edition packaging.
At stores, customers have access to more than 150 NYX product SKUs including mainstay items, such as its Jumbo Eye Pencil, Eye Shadow Palettes, Extra Creamy Round Lipstick and Slide on Pencil. In addition, specialty products such as the award-winning The Curve, Shine Killer, Pore Filler, Matte Lipstick and Soft Matte Lip Cream also will be available. Target also will feature NYX’s newest product launches, as well as specialty items from the line.
MinuteClinic opens first clinic in Southwest Virginia
WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has opened its first clinic inside a CVS/pharmacy store in Southwest Virginia with five additional locations planned for September and October.
With the new opening, there are now 27 MinuteClinic locations in Virginia. The additional clinic locations slated to open in September and October will be in Hollins, Lynchburg, Radford, Roanoke and Salem.
"Since opening our first store-based clinic in Virginia in 2006, we have helped expand access to high-quality, convenient and affordable care to thousands of residents who have visited us at convenient CVS/pharmacy locations near where they live and work," stated Andrew Sussman, president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark. "We believe MinuteClinic can be part of the solution to Virginia’s efforts to broaden access to quality health services."
Reports: FDA says carve-out bills ‘undermine trust’ in biosimilars
NEW YORK — The Food and Drug Administration is concerned about bills in several state legislatures that seek to restrict pharmacists’ ability to dispense biosimilars, according to published reports.
Biopharma-Reporter.com quoted an FDA spokeswoman as saying "efforts to undermine trust in these products" were cause for worry and did not serve the interests of patients.
Earlier this week, the lower house of California’s General Assembly passed a bill, which had received support from biotech companies like Amgen and Genentech, that would require pharmacists to notify physicians and patients if they swap out a branded biotech drug for a biosimilar. However, the bill contained a sunset clause that means it’s only in effect through Jan. 1, 2017, and Gov. Jerry Brown has not indicated whether or not he will sign it.
Similar bills have failed in several states, like Illinois and Florida, while passing in a few others, notably Virginia and North Dakota.